Business ❯ Healthcare ❯ Pharmaceuticals

Oncology

Drug Development Clinical Trials Keytruda Data Collaboration Cancer Immunotherapy Precision Medicine Gastrointestinal Cancers Pediatric Cancer Antibody-Drug Conjugates Product Development

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

Durable results are pushing doctors to start the drug first.

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Gilead Expands Tempus Partnership for Enterprise Access to AI Oncology Platform

Gilead to Acquire Tubulis for Up to $5 Billion to Boost Cancer ADC Pipeline

Karyopharm Raises $30 Million in RA Capital Private Placement

C-Further Launches First Pediatric Cancer Programs, Taps MiNK for PRAME iNKT Therapy

Merck Lifts Mid-2030s Revenue Goal to $70 Billion From Emerging Businesses

Merck Sets $70 Billion Mid-2030s Revenue Goal at JPM Conference as Shares Dip

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

AstraZeneca Posts Record Quarter as Cancer Drugs Lift Sales, Keeps Guidance

J&J to Spin Off $9 Billion Orthopedics Unit as DePuy Synthes Within Two Years

Pfizer Lifts 2025 EPS Outlook, Targets $7.7 Billion in Savings as Dividend Draws Interest

FTSE 100 Companies Deliver Record Profits but Flag Trade Risks

Biontech Reports Q1 Loss as Focus Shifts to mRNA Cancer Therapies

GSK Acquires US Biotech IDRx in $1.15 Billion Deal to Advance Rare Cancer Treatment

Johnson & Johnson Raises Revenue Forecast Despite Legal Costs Impact